Advertisement
Home »

Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study.

Jan 23, 2023

ABOUT THE EXPERTS

  • Youran Xu

    Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson, Beijing, China. yxu69@its.jnj.com.

    Hsingwen Chung

    Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson, Titusville, NJ, USA.

    Meng Shu

    Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson, Shanghai, China.

    Yanfang Liu

    Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson, Singapore, Singapore.

    Yongjing Zhang

    Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson, Shanghai, China.

    Hong Qiu

    Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson, Titusville, NJ, USA. hqiu@its.jnj.com.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement